Close
Back to PAND Stock Lookup

(PAND) – Company Press Releases

Apr 1, 2021 08:30 AM Merck Completes Acquisition of Pandion Therapeutics
Mar 4, 2021 06:45 AM Merck Begins Tender Offer to Acquire Pandion Therapeutics
Feb 25, 2021 11:49 AM PANDION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PAND and Encourages Investors to Contact the Firm
Feb 25, 2021 06:45 AM Merck to Acquire Pandion Therapeutics
Feb 22, 2021 08:30 AM Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting
Feb 22, 2021 08:30 AM Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting
Feb 18, 2021 08:30 AM Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Feb 18, 2021 08:30 AM Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Jan 4, 2021 08:00 AM Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells
Jan 4, 2021 08:00 AM Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expanded Regulatory T cells
Dec 15, 2020 08:00 AM NodThera Appoints Chief Medical Officer and Chief Financial Officer
Dec 3, 2020 08:00 AM Pandion Therapeutics Appoints Katina Dorton to its Board of Directors
Dec 3, 2020 08:00 AM Pandion Therapeutics Appoints Katina Dorton to its Board of Directors
Nov 16, 2020 04:01 PM Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 16, 2020 04:01 PM Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 10, 2020 08:00 AM Pandion Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
Nov 10, 2020 08:00 AM Pandion Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference
Oct 28, 2020 08:00 AM Pandion Therapeutics Highlights Potential of Modular Biologics Pipeline for the Treatment of Autoimmune Diseases at FOCIS 2020
Oct 28, 2020 08:00 AM Pandion Therapeutics Highlights Potential of Modular Biologics Pipeline for the Treatment of Autoimmune Diseases at FOCIS 2020
Sep 24, 2020 08:00 AM Pandion Therapeutics to Participate in Panel Discussion at Stifel 2020 Immunology & Inflammation Virtual Summit
Sep 24, 2020 08:00 AM Pandion Therapeutics to Participate in Panel Discussion at Stifel 2020 Immunology & Inflammation Virtual Summit
Sep 10, 2020 08:00 AM Pandion Therapeutics to Present at Morgan Stanley Global Healthcare Conference
Sep 10, 2020 08:00 AM Pandion Therapeutics to Present at Morgan Stanley Global Healthcare Conference
Aug 31, 2020 04:05 PM Pandion Reports Second Quarter 2020 Financial Results and Provides Business Update
Aug 31, 2020 04:05 PM Pandion Reports Second Quarter 2020 Financial Results and Provides Business Update
Jul 16, 2020 09:01 PM Pandion Therapeutics Announces Pricing of Initial Public Offering
Jul 16, 2020 09:01 PM Pandion Therapeutics Announces Pricing of Initial Public Offering

Back to PAND Stock Lookup